Startup investors may not be pressing pause on the venture ecosystem, but the landscape saw a noticeable recalibration in the size of mega-rounds over the past week. While capital continued to flow freely into high-growth sectors, only two U.S.-based startups managed to secure financings reaching into the multiple hundreds of millions of dollars.
The week’s capital deployment was anchored by massive investments in artificial intelligence infrastructure and construction technology, alongside notable injections of venture capital into biotech, healthcare workflows, specialized insurance, and semiconductor systems. Even as the broader market displayed a slight contraction in the frequency of ultra-large deals compared to previous weeks, high-performing companies with proven metrics continued to command substantial valuations from prominent institutional investors.
Taking the top spot for the week by a wide margin was AI infrastructure provider Modal Labs, which dominated headlines with a massive Series D financing. Meanwhile, construction automation unicorn Icon secured the second-largest spot, demonstrating that investors remain eager to back transformative physical technologies alongside software solutions.
The Week’s Top Funding Rounds
Leading the charge for the week of October 10 through October 16, New York-based Modal Labs pulled in a staggering $750 million in Series D funding. The round was led by prominent venture capital firm Accel and pushed the company’s valuation to a remarkable $15.75 billion. Modal Labs provides specialized cloud infrastructure designed specifically to handle AI inference and other heavy computational applications. The company’s ability to secure such a massive check is underpinned by exceptional business performance; Modal Labs announced that it recently crossed a significant financial milestone, exceeding an annual revenue run rate of $1 billion.
Securing the second-largest deal of the week was Austin, Texas-based Icon. The construction technology unicorn, known for developing advanced robotic construction systems that specialize in 3D-printed homes, closed on $200 million in Series D funding. The round was co-led by heavyweight institutional investors Baillie Gifford and BlackRock. Icon’s latest influx of capital comes as the company experiences rapid commercial scaling, with management reporting that the firm is currently on pace to achieve a fourfold increase in revenue growth throughout 2026.
Biotechnology and genetic medicine also claimed prominent positions among the week’s top financings, proving that healthcare innovation remains a priority for deep-pocketed investors. Boston-based Soufflé Therapeutics, a developer focusing on advanced RNA therapies, raised $135 million in a Series B funding round. The financing was led by the Juvia Group as part of a large and diverse syndicate of investors looking to back the company’s therapeutic pipeline.
Similarly, Menlo Park, California-based Estuary Biotherapeutics officially launched with a substantial $103 million in total financing. The company, which is developing targeted genetic medicines for patients suffering from serious and chronic kidney diseases, structured its entry with $93 million in a Series A round led by RA Capital Management, supplemented by $10 million in previously undisclosed seed capital.
Artificial intelligence tooling and enterprise solutions continued to attract institutional capital. Labelbox, a San Francisco-based developer of technology used to train and evaluate AI models while deploying agents that improve dynamically with experience, picked up $100 million in Series E funding. The financing for the eight-year-old enterprise was led by Infinitum Partners.
Healthcare artificial intelligence also secured a major win with Suki. The Redwood City, California-based provider of AI tools designed to transform clinical conversations into actionable intelligence for medical documentation, coding, and broader healthcare workflows, announced a $90 million Series E funding round. The financing drew participation from key backers including Healthier Capital and Crosslink Capital.
Addressing the critical and often overlooked market of caregiving, San Francisco startup Abby Care closed on $82 million in Series C funding. The five-year-old platform, which empowers family members to become certified, paid caregivers capable of delivering professional-grade care directly in the home, secured its latest round led by Transformation Capital.
In the insurance sector, San Francisco-based Stand secured $70 million in a Series C financing round that elevated the three-year-old company to a $1 billion valuation. Stand specializes in providing crucial property insurance solutions for residential homes situated in geographic areas facing heightened risks of natural disasters—a pressing market need given shifting climate patterns. Saga Ventures led the investment round.
Rounding out the top tier of the week’s financings, Mueon Corp. completed a $65 million Series A funding round. Based in Portland, Oregon, Mueon is a semiconductor systems company building a modular platform explicitly engineered for AI and hyperscale computing demands. The round was led by Maverick Silicon. Finally, New York-based North.cloud, which provides an infrastructure spend intelligence and automation platform tailored to help enterprises manage their cloud and AI expenses, raised $60 million in a Series B round led by PeakSpan Capital.
Tracking the Market
The weekly roundups track the largest announced funding rounds within the Crunchbase database raised by U.S.-based companies. While the database captures the vast minor and major movements across the venture landscape, minor time lags can occasionally occur due to late-week reporting and announcement disclosures.
As the venture ecosystem progresses through the remainder of the year, investors appear to be exercising a balanced approach—maintaining immense financial support for category-defining AI and infrastructure leaders while remaining selective across emerging sectors.
